The Meningioma Symposium 2026, organized by the Wiener Medizinische Akademie (WMA) and officially endorsed by the European Association of Neuro-Oncology (EANO) and the Society for Neuro-Oncology (SNO), will take place on 28 September 2026 on Isola Tiberina in Rome, Italy.

The focused, single-track, in-person meeting will bring together international experts in meningioma research and clinical care, linking basic science, translational research, and clinical practice.

The programme will feature four main sessions on molecular markers, treatment, disease models, and host factors, with invited talks, selected abstract presentations, roundtable discussions, and networking. Scientific topics include methylation classification, tumor microenvironment, preclinical models, biomarker-guided strategies, surgery, radiation, systemic therapies, and integrated treatment approaches.

Early registration is available through 12 August 2026, with fees starting at €250 for regular attendees, €125 for EANO/SNO members, €80 for nurses/AHPs and trainees, and €700 for industry representatives.